Professional Documents
Culture Documents
1http://timesofindia.indiatimes.com/india/Patients-pay-three-times-import-price-forstents/articleshow/42483945.cms
2http://timesofindia.indiatimes.com/india/Patients-pay-three-times-import-price-forstents/articleshow/42483945.cms
report, the prices of bare metal stents could be capped at 19,000 and the maximum price
for drug eluting stents may be fixed at 28,000. 8 In comparison to the US, this range is
seen as equal to or slightly higher, given that the US has an insurance and reimbursementbased healthcare system and patients do not pay the entire expense. Industry estimates
suggest stent prices in China, Singapore and Malaysia are roughly one and half times
higher as compared to India.9 Absence of the price regulation led to a huge exploitation of
consumers due to extreme overpricing of stents, especially imported brands, as stated by
the NHSRC report. This report faced opposition from the Medical Devices industry,
which is split up into domestic and multinational players.
According to the global players, attention should be paid to the quality of the imported
products and overall hospitalization charges before imposing a price control. On the other
hand, the domestic stent makers emphasize on the steep information symmetry and
aggressive promotions of big companies as reasons for Indias import dependency.
In order to regulate the Medical Devices industry, a Draft National Medical Policy was
introduced, which recommended for the creation of an autonomous body called the
National Medical Devices Authority (NDMA) which aims at controlling the price of the
Medical Devices by including them under the Essential Commodities Act. It also aims at
introducing separate pricing division in the drug pricing regulator, NPPA.
As per the Draft, government may announce a separate policy enunciating the principles
for regulating the prices of identified medical devices and implement the same by
notifying a separate Medical Devices Prices Control Order (MDPCO). In a patientfriendly measure, the draft mentions adopting policies on efficacy and safety testing, and
quality control through a 'Made in India' marking (BIS) specific to medical devices in line
with global standards.10
8 http://health.economictimes.indiatimes.com/news/medical-devices/capping-cardiac-stent-prices-infinal-lap/48445997
9 http://health.economictimes.indiatimes.com/news/medical-devices/capping-cardiac-stent-prices-infinal-lap/48445997
10 http://pharmaceuticals.gov.in/sites/default/files/Draft%20National%20Medical%20Device
%20Policy%20-%202015.pdf